DURHAM, N.C., June 22, 2020 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the […]
Esperion to Receive $150 Million Milestone Payment in June Esperion Completes Transfer of Marketing Authorization Approvals (MAAs) for NILEMDO™ (bempedoic acid) […]
Upgraded Manufacturing Process Being Used For Production Of Pivotal Stage Clinical Trial MaterialsGAINESVILLE, Fla., and CAMBRIDGE, Mass., June 22, 2020 […]